Literature DB >> 24889358

A complex genomic abnormality found in a patient with antithrombin deficiency and autoimmune disease-like symptoms.

Io Kato1, Yuki Takagi, Yumi Ando, Yuki Nakamura, Moe Murata, Akira Takagi, Takashi Murate, Tadashi Matsushita, Tadaaki Nakashima, Tetsuhito Kojima.   

Abstract

Hereditary antithrombin (AT) deficiency is an autosomal dominant thrombophilic disorder caused by SERPINC1 abnormality. In the present study, we analyzed SERPINC1 in a Japanese patient with AT deficiency and autoimmune disease-like symptoms. Direct sequencing and multiplex ligation-dependent probe amplification revealed that the patient was hemizygous for the entire SERPINC1 deletion. Single nucleotide polymorphism genotyping, gene dose measurement, and long-range polymerase chain reaction (PCR) followed by mapping PCR and direct sequencing of the long-range PCR products revealed that the patient had an approximately 111-kb gene deletion from exon 2 of ZBTB37 to intron 5 of RC3H1, including the entire SERPINC1 in chromosome 1. We also found a 7-bp insertion of an unknown origin in the breakpoint, which may be a combination of three parts with a few base-pair microhomologies, resulting from a replication-based process known as 'fork stalling and template switching'. Because RC3H1, which encodes the protein roquin is involved in the repression of self-immune responses, the autoimmune disease-like symptoms of the patient may have resulted from this gene defect. In conclusion, we identified an entire SERPINC1 deletion together with a large deletion of RC3H1 in an AT-deficient patient with autoimmune disease-like symptoms.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24889358     DOI: 10.1007/s12185-014-1596-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  19 in total

1.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

Authors:  Jan P Schouten; Cathal J McElgunn; Raymond Waaijer; Danny Zwijnenburg; Filip Diepvens; Gerard Pals
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

2.  INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.

Authors:  O EGEBERG
Journal:  Thromb Diath Haemorrh       Date:  1965-06-15

Review 3.  Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism.

Authors:  R D Rosenberg
Journal:  Am J Med       Date:  1989-09-11       Impact factor: 4.965

4.  Complete antithrombin deficiency in mice results in embryonic lethality.

Authors:  K Ishiguro; T Kojima; K Kadomatsu; Y Nakayama; A Takagi; M Suzuki; N Takeda; M Ito; K Yamamoto; T Matsushita; K Kusugami; T Muramatsu; H Saito
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

5.  A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity.

Authors:  Carola G Vinuesa; Matthew C Cook; Constanza Angelucci; Vicki Athanasopoulos; Lixin Rui; Kim M Hill; Di Yu; Heather Domaschenz; Belinda Whittle; Teresa Lambe; Ian S Roberts; Richard R Copley; John I Bell; Richard J Cornall; Christopher C Goodnow
Journal:  Nature       Date:  2005-05-26       Impact factor: 49.962

6.  Molecular basis of antithrombin deficiency in four Japanese patients with antithrombin gene abnormalities including two novel mutations.

Authors:  Mayu Kyotani; Kaoru Okumura; Akira Takagi; Takashi Murate; Koji Yamamoto; Tadashi Matsushita; Motoi Sugimura; Naohiro Kanayama; Takao Kobayashi; Hidehiko Saito; Tetsuhito Kojima
Journal:  Am J Hematol       Date:  2007-08       Impact factor: 10.047

7.  Detection and characterisation of large SERPINC1 deletions in type I inherited antithrombin deficiency.

Authors:  Véronique Picard; Jian-Min Chen; Brigitte Tardy; Marie-Françoise Aillaud; Christine Boiteux-Vergnes; Marie Dreyfus; Joseph Emmerich; Cécile Lavenu-Bombled; Ulrike Nowak-Göttl; Nathalie Trillot; Martine Aiach; Martine Alhenc-Gelas
Journal:  Hum Genet       Date:  2009-09-17       Impact factor: 4.132

8.  Roquin promotes constitutive mRNA decay via a conserved class of stem-loop recognition motifs.

Authors:  Kathrin Leppek; Johanna Schott; Sonja Reitter; Fabian Poetz; Ming C Hammond; Georg Stoecklin
Journal:  Cell       Date:  2013-05-09       Impact factor: 41.582

9.  The DNA replication FoSTeS/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans.

Authors:  Feng Zhang; Mehrdad Khajavi; Anne M Connolly; Charles F Towne; Sat Dev Batish; James R Lupski
Journal:  Nat Genet       Date:  2009-06-21       Impact factor: 38.330

10.  Mechanisms for human genomic rearrangements.

Authors:  Wenli Gu; Feng Zhang; James R Lupski
Journal:  Pathogenetics       Date:  2008-11-03
View more
  4 in total

1.  SVA retrotransposition in exon 6 of the coagulation factor IX gene causing severe hemophilia B.

Authors:  Yuki Nakamura; Moe Murata; Yuki Takagi; Toshihiro Kozuka; Yukiko Nakata; Ryo Hasebe; Akira Takagi; Jun-ichi Kitazawa; Midori Shima; Tetsuhito Kojima
Journal:  Int J Hematol       Date:  2015-03-05       Impact factor: 2.490

2.  A human immune dysregulation syndrome characterized by severe hyperinflammation with a homozygous nonsense Roquin-1 mutation.

Authors:  S J Tavernier; V Athanasopoulos; P Verloo; G Behrens; J Staal; D J Bogaert; L Naesens; M De Bruyne; S Van Gassen; E Parthoens; J Ellyard; J Cappello; L X Morris; H Van Gorp; G Van Isterdael; Y Saeys; M Lamkanfi; P Schelstraete; J Dehoorne; V Bordon; R Van Coster; B N Lambrecht; B Menten; R Beyaert; C G Vinuesa; V Heissmeyer; M Dullaers; F Haerynck
Journal:  Nat Commun       Date:  2019-10-21       Impact factor: 14.919

3.  Roquin is a major mediator of iron-regulated changes to transferrin receptor-1 mRNA stability.

Authors:  Victor M Corral; Eric R Schultz; Richard S Eisenstein; Gregory J Connell
Journal:  iScience       Date:  2021-03-26

4.  Long-Read Sequencing Identifies the First Retrotransposon Insertion and Resolves Structural Variants Causing Antithrombin Deficiency.

Authors:  Belén de la Morena-Barrio; Jonathan Stephens; María Eugenia de la Morena-Barrio; Luca Stefanucci; José Padilla; Antonia Miñano; Nicholas Gleadall; Juan Luis García; María Fernanda López-Fernández; Pierre-Emmanuel Morange; Marja Puurunen; Anetta Undas; Francisco Vidal; Frances Lucy Raymond; Vicente Vicente; Willem H Ouwehand; Javier Corral; Alba Sanchis-Juan
Journal:  Thromb Haemost       Date:  2022-06-28       Impact factor: 6.681

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.